Global Drugs for Traveler's Diarrhea Market Growth 2024-2030

February 2024 | 93 pages | ID: G41FF7C2C313EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

According to our LPI (LP Information) latest study, the global Drugs for Traveler's Diarrhea market size was valued at US$ 768.3 million in 2023. With growing demand in downstream market, the Drugs for Traveler's Diarrhea is forecast to a readjusted size of US$ 1156.5 million by 2030 with a CAGR of 6.0% during review period.

The research report highlights the growth potential of the global Drugs for Traveler's Diarrhea market. Drugs for Traveler's Diarrhea are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Drugs for Traveler's Diarrhea. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Drugs for Traveler's Diarrhea market.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Key Features:

The report on Drugs for Traveler's Diarrhea market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Drugs for Traveler's Diarrhea market. It may include historical data, market segmentation by Type (e.g., Anti-motility agents, Bismuth Subsalicylate (Pepto-Bismol)), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Drugs for Traveler's Diarrhea market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Drugs for Traveler's Diarrhea market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Drugs for Traveler's Diarrhea industry. This include advancements in Drugs for Traveler's Diarrhea technology, Drugs for Traveler's Diarrhea new entrants, Drugs for Traveler's Diarrhea new investment, and other innovations that are shaping the future of Drugs for Traveler's Diarrhea.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Drugs for Traveler's Diarrhea market. It includes factors influencing customer ' purchasing decisions, preferences for Drugs for Traveler's Diarrhea product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Drugs for Traveler's Diarrhea market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Drugs for Traveler's Diarrhea market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Drugs for Traveler's Diarrhea market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Drugs for Traveler's Diarrhea industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Drugs for Traveler's Diarrhea market.

Market Segmentation:

Drugs for Traveler's Diarrhea market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Segmentation by type
  • Anti-motility agents
  • Bismuth Subsalicylate (Pepto-Bismol)
  • Antibiotics
Segmentation by application
  • Adult
  • Children
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • GSK
  • Salix Pharmaceuticals
  • Chiesi Farmaceutici
  • Cosmo Pharmaceuticals
  • Nippon Shinyaku
  • Prokarium Limited
  • Scandinavian Biopharma
  • Sigmoid Pharma
Key Questions Addressed in this Report

What is the 10-year outlook for the global Drugs for Traveler's Diarrhea market?

What factors are driving Drugs for Traveler's Diarrhea market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Drugs for Traveler's Diarrhea market opportunities vary by end market size?

How does Drugs for Traveler's Diarrhea break out type, application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Drugs for Traveler's Diarrhea Annual Sales 2019-2030
  2.1.2 World Current & Future Analysis for Drugs for Traveler's Diarrhea by Geographic Region, 2019, 2023 & 2030
  2.1.3 World Current & Future Analysis for Drugs for Traveler's Diarrhea by Country/Region, 2019, 2023 & 2030
2.2 Drugs for Traveler's Diarrhea Segment by Type
  2.2.1 Anti-motility agents
  2.2.2 Bismuth Subsalicylate (Pepto-Bismol)
  2.2.3 Antibiotics
2.3 Drugs for Traveler's Diarrhea Sales by Type
  2.3.1 Global Drugs for Traveler's Diarrhea Sales Market Share by Type (2019-2024)
  2.3.2 Global Drugs for Traveler's Diarrhea Revenue and Market Share by Type (2019-2024)
  2.3.3 Global Drugs for Traveler's Diarrhea Sale Price by Type (2019-2024)
2.4 Drugs for Traveler's Diarrhea Segment by Application
  2.4.1 Adult
  2.4.2 Children
2.5 Drugs for Traveler's Diarrhea Sales by Application
  2.5.1 Global Drugs for Traveler's Diarrhea Sale Market Share by Application (2019-2024)
  2.5.2 Global Drugs for Traveler's Diarrhea Revenue and Market Share by Application (2019-2024)
  2.5.3 Global Drugs for Traveler's Diarrhea Sale Price by Application (2019-2024)

3 GLOBAL DRUGS FOR TRAVELER'S DIARRHEA BY COMPANY

3.1 Global Drugs for Traveler's Diarrhea Breakdown Data by Company
  3.1.1 Global Drugs for Traveler's Diarrhea Annual Sales by Company (2019-2024)
  3.1.2 Global Drugs for Traveler's Diarrhea Sales Market Share by Company (2019-2024)
3.2 Global Drugs for Traveler's Diarrhea Annual Revenue by Company (2019-2024)
  3.2.1 Global Drugs for Traveler's Diarrhea Revenue by Company (2019-2024)
  3.2.2 Global Drugs for Traveler's Diarrhea Revenue Market Share by Company (2019-2024)
3.3 Global Drugs for Traveler's Diarrhea Sale Price by Company
3.4 Key Manufacturers Drugs for Traveler's Diarrhea Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Drugs for Traveler's Diarrhea Product Location Distribution
  3.4.2 Players Drugs for Traveler's Diarrhea Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR DRUGS FOR TRAVELER'S DIARRHEA BY GEOGRAPHIC REGION

4.1 World Historic Drugs for Traveler's Diarrhea Market Size by Geographic Region (2019-2024)
  4.1.1 Global Drugs for Traveler's Diarrhea Annual Sales by Geographic Region (2019-2024)
  4.1.2 Global Drugs for Traveler's Diarrhea Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Drugs for Traveler's Diarrhea Market Size by Country/Region (2019-2024)
  4.2.1 Global Drugs for Traveler's Diarrhea Annual Sales by Country/Region (2019-2024)
  4.2.2 Global Drugs for Traveler's Diarrhea Annual Revenue by Country/Region (2019-2024)
4.3 Americas Drugs for Traveler's Diarrhea Sales Growth
4.4 APAC Drugs for Traveler's Diarrhea Sales Growth
4.5 Europe Drugs for Traveler's Diarrhea Sales Growth
4.6 Middle East & Africa Drugs for Traveler's Diarrhea Sales Growth

5 AMERICAS

5.1 Americas Drugs for Traveler's Diarrhea Sales by Country
  5.1.1 Americas Drugs for Traveler's Diarrhea Sales by Country (2019-2024)
  5.1.2 Americas Drugs for Traveler's Diarrhea Revenue by Country (2019-2024)
5.2 Americas Drugs for Traveler's Diarrhea Sales by Type
5.3 Americas Drugs for Traveler's Diarrhea Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Drugs for Traveler's Diarrhea Sales by Region
  6.1.1 APAC Drugs for Traveler's Diarrhea Sales by Region (2019-2024)
  6.1.2 APAC Drugs for Traveler's Diarrhea Revenue by Region (2019-2024)
6.2 APAC Drugs for Traveler's Diarrhea Sales by Type
6.3 APAC Drugs for Traveler's Diarrhea Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Drugs for Traveler's Diarrhea by Country
  7.1.1 Europe Drugs for Traveler's Diarrhea Sales by Country (2019-2024)
  7.1.2 Europe Drugs for Traveler's Diarrhea Revenue by Country (2019-2024)
7.2 Europe Drugs for Traveler's Diarrhea Sales by Type
7.3 Europe Drugs for Traveler's Diarrhea Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Drugs for Traveler's Diarrhea by Country
  8.1.1 Middle East & Africa Drugs for Traveler's Diarrhea Sales by Country (2019-2024)
  8.1.2 Middle East & Africa Drugs for Traveler's Diarrhea Revenue by Country (2019-2024)
8.2 Middle East & Africa Drugs for Traveler's Diarrhea Sales by Type
8.3 Middle East & Africa Drugs for Traveler's Diarrhea Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Drugs for Traveler's Diarrhea
10.3 Manufacturing Process Analysis of Drugs for Traveler's Diarrhea
10.4 Industry Chain Structure of Drugs for Traveler's Diarrhea

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Drugs for Traveler's Diarrhea Distributors
11.3 Drugs for Traveler's Diarrhea Customer

12 WORLD FORECAST REVIEW FOR DRUGS FOR TRAVELER'S DIARRHEA BY GEOGRAPHIC REGION

12.1 Global Drugs for Traveler's Diarrhea Market Size Forecast by Region
  12.1.1 Global Drugs for Traveler's Diarrhea Forecast by Region (2025-2030)
  12.1.2 Global Drugs for Traveler's Diarrhea Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Drugs for Traveler's Diarrhea Forecast by Type
12.7 Global Drugs for Traveler's Diarrhea Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 GSK
  13.1.1 GSK Company Information
  13.1.2 GSK Drugs for Traveler's Diarrhea Product Portfolios and Specifications
  13.1.3 GSK Drugs for Traveler's Diarrhea Sales, Revenue, Price and Gross Margin (2019-2024)
  13.1.4 GSK Main Business Overview
  13.1.5 GSK Latest Developments
13.2 Salix Pharmaceuticals
  13.2.1 Salix Pharmaceuticals Company Information
  13.2.2 Salix Pharmaceuticals Drugs for Traveler's Diarrhea Product Portfolios and Specifications
  13.2.3 Salix Pharmaceuticals Drugs for Traveler's Diarrhea Sales, Revenue, Price and Gross Margin (2019-2024)
  13.2.4 Salix Pharmaceuticals Main Business Overview
  13.2.5 Salix Pharmaceuticals Latest Developments
13.3 Chiesi Farmaceutici
  13.3.1 Chiesi Farmaceutici Company Information
  13.3.2 Chiesi Farmaceutici Drugs for Traveler's Diarrhea Product Portfolios and Specifications
  13.3.3 Chiesi Farmaceutici Drugs for Traveler's Diarrhea Sales, Revenue, Price and Gross Margin (2019-2024)
  13.3.4 Chiesi Farmaceutici Main Business Overview
  13.3.5 Chiesi Farmaceutici Latest Developments
13.4 Cosmo Pharmaceuticals
  13.4.1 Cosmo Pharmaceuticals Company Information
  13.4.2 Cosmo Pharmaceuticals Drugs for Traveler's Diarrhea Product Portfolios and Specifications
  13.4.3 Cosmo Pharmaceuticals Drugs for Traveler's Diarrhea Sales, Revenue, Price and Gross Margin (2019-2024)
  13.4.4 Cosmo Pharmaceuticals Main Business Overview
  13.4.5 Cosmo Pharmaceuticals Latest Developments
13.5 Nippon Shinyaku
  13.5.1 Nippon Shinyaku Company Information
  13.5.2 Nippon Shinyaku Drugs for Traveler's Diarrhea Product Portfolios and Specifications
  13.5.3 Nippon Shinyaku Drugs for Traveler's Diarrhea Sales, Revenue, Price and Gross Margin (2019-2024)
  13.5.4 Nippon Shinyaku Main Business Overview
  13.5.5 Nippon Shinyaku Latest Developments
13.6 Prokarium Limited
  13.6.1 Prokarium Limited Company Information
  13.6.2 Prokarium Limited Drugs for Traveler's Diarrhea Product Portfolios and Specifications
  13.6.3 Prokarium Limited Drugs for Traveler's Diarrhea Sales, Revenue, Price and Gross Margin (2019-2024)
  13.6.4 Prokarium Limited Main Business Overview
  13.6.5 Prokarium Limited Latest Developments
13.7 Scandinavian Biopharma
  13.7.1 Scandinavian Biopharma Company Information
  13.7.2 Scandinavian Biopharma Drugs for Traveler's Diarrhea Product Portfolios and Specifications
  13.7.3 Scandinavian Biopharma Drugs for Traveler's Diarrhea Sales, Revenue, Price and Gross Margin (2019-2024)
  13.7.4 Scandinavian Biopharma Main Business Overview
  13.7.5 Scandinavian Biopharma Latest Developments
13.8 Sigmoid Pharma
  13.8.1 Sigmoid Pharma Company Information
  13.8.2 Sigmoid Pharma Drugs for Traveler's Diarrhea Product Portfolios and Specifications
  13.8.3 Sigmoid Pharma Drugs for Traveler's Diarrhea Sales, Revenue, Price and Gross Margin (2019-2024)
  13.8.4 Sigmoid Pharma Main Business Overview
  13.8.5 Sigmoid Pharma Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. Drugs for Traveler's Diarrhea Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Drugs for Traveler's Diarrhea Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Anti-motility agents
Table 4. Major Players of Bismuth Subsalicylate (Pepto-Bismol)
Table 5. Major Players of Antibiotics
Table 6. Global Drugs for Traveler's Diarrhea Sales by Type (2019-2024) & (K Pcs)
Table 7. Global Drugs for Traveler's Diarrhea Sales Market Share by Type (2019-2024)
Table 8. Global Drugs for Traveler's Diarrhea Revenue by Type (2019-2024) & ($ million)
Table 9. Global Drugs for Traveler's Diarrhea Revenue Market Share by Type (2019-2024)
Table 10. Global Drugs for Traveler's Diarrhea Sale Price by Type (2019-2024) & (USD/Pcs)
Table 11. Global Drugs for Traveler's Diarrhea Sales by Application (2019-2024) & (K Pcs)
Table 12. Global Drugs for Traveler's Diarrhea Sales Market Share by Application (2019-2024)
Table 13. Global Drugs for Traveler's Diarrhea Revenue by Application (2019-2024)
Table 14. Global Drugs for Traveler's Diarrhea Revenue Market Share by Application (2019-2024)
Table 15. Global Drugs for Traveler's Diarrhea Sale Price by Application (2019-2024) & (USD/Pcs)
Table 16. Global Drugs for Traveler's Diarrhea Sales by Company (2019-2024) & (K Pcs)
Table 17. Global Drugs for Traveler's Diarrhea Sales Market Share by Company (2019-2024)
Table 18. Global Drugs for Traveler's Diarrhea Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Drugs for Traveler's Diarrhea Revenue Market Share by Company (2019-2024)
Table 20. Global Drugs for Traveler's Diarrhea Sale Price by Company (2019-2024) & (USD/Pcs)
Table 21. Key Manufacturers Drugs for Traveler's Diarrhea Producing Area Distribution and Sales Area
Table 22. Players Drugs for Traveler's Diarrhea Products Offered
Table 23. Drugs for Traveler's Diarrhea Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Drugs for Traveler's Diarrhea Sales by Geographic Region (2019-2024) & (K Pcs)
Table 27. Global Drugs for Traveler's Diarrhea Sales Market Share Geographic Region (2019-2024)
Table 28. Global Drugs for Traveler's Diarrhea Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Drugs for Traveler's Diarrhea Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Drugs for Traveler's Diarrhea Sales by Country/Region (2019-2024) & (K Pcs)
Table 31. Global Drugs for Traveler's Diarrhea Sales Market Share by Country/Region (2019-2024)
Table 32. Global Drugs for Traveler's Diarrhea Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Drugs for Traveler's Diarrhea Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Drugs for Traveler's Diarrhea Sales by Country (2019-2024) & (K Pcs)
Table 35. Americas Drugs for Traveler's Diarrhea Sales Market Share by Country (2019-2024)
Table 36. Americas Drugs for Traveler's Diarrhea Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Drugs for Traveler's Diarrhea Revenue Market Share by Country (2019-2024)
Table 38. Americas Drugs for Traveler's Diarrhea Sales by Type (2019-2024) & (K Pcs)
Table 39. Americas Drugs for Traveler's Diarrhea Sales by Application (2019-2024) & (K Pcs)
Table 40. APAC Drugs for Traveler's Diarrhea Sales by Region (2019-2024) & (K Pcs)
Table 41. APAC Drugs for Traveler's Diarrhea Sales Market Share by Region (2019-2024)
Table 42. APAC Drugs for Traveler's Diarrhea Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Drugs for Traveler's Diarrhea Revenue Market Share by Region (2019-2024)
Table 44. APAC Drugs for Traveler's Diarrhea Sales by Type (2019-2024) & (K Pcs)
Table 45. APAC Drugs for Traveler's Diarrhea Sales by Application (2019-2024) & (K Pcs)
Table 46. Europe Drugs for Traveler's Diarrhea Sales by Country (2019-2024) & (K Pcs)
Table 47. Europe Drugs for Traveler's Diarrhea Sales Market Share by Country (2019-2024)
Table 48. Europe Drugs for Traveler's Diarrhea Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Drugs for Traveler's Diarrhea Revenue Market Share by Country (2019-2024)
Table 50. Europe Drugs for Traveler's Diarrhea Sales by Type (2019-2024) & (K Pcs)
Table 51. Europe Drugs for Traveler's Diarrhea Sales by Application (2019-2024) & (K Pcs)
Table 52. Middle East & Africa Drugs for Traveler's Diarrhea Sales by Country (2019-2024) & (K Pcs)
Table 53. Middle East & Africa Drugs for Traveler's Diarrhea Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Drugs for Traveler's Diarrhea Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Drugs for Traveler's Diarrhea Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Drugs for Traveler's Diarrhea Sales by Type (2019-2024) & (K Pcs)
Table 57. Middle East & Africa Drugs for Traveler's Diarrhea Sales by Application (2019-2024) & (K Pcs)
Table 58. Key Market Drivers & Growth Opportunities of Drugs for Traveler's Diarrhea
Table 59. Key Market Challenges & Risks of Drugs for Traveler's Diarrhea
Table 60. Key Industry Trends of Drugs for Traveler's Diarrhea
Table 61. Drugs for Traveler's Diarrhea Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Drugs for Traveler's Diarrhea Distributors List
Table 64. Drugs for Traveler's Diarrhea Customer List
Table 65. Global Drugs for Traveler's Diarrhea Sales Forecast by Region (2025-2030) & (K Pcs)
Table 66. Global Drugs for Traveler's Diarrhea Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Drugs for Traveler's Diarrhea Sales Forecast by Country (2025-2030) & (K Pcs)
Table 68. Americas Drugs for Traveler's Diarrhea Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Drugs for Traveler's Diarrhea Sales Forecast by Region (2025-2030) & (K Pcs)
Table 70. APAC Drugs for Traveler's Diarrhea Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Drugs for Traveler's Diarrhea Sales Forecast by Country (2025-2030) & (K Pcs)
Table 72. Europe Drugs for Traveler's Diarrhea Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Drugs for Traveler's Diarrhea Sales Forecast by Country (2025-2030) & (K Pcs)
Table 74. Middle East & Africa Drugs for Traveler's Diarrhea Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Drugs for Traveler's Diarrhea Sales Forecast by Type (2025-2030) & (K Pcs)
Table 76. Global Drugs for Traveler's Diarrhea Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Drugs for Traveler's Diarrhea Sales Forecast by Application (2025-2030) & (K Pcs)
Table 78. Global Drugs for Traveler's Diarrhea Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. GSK Basic Information, Drugs for Traveler's Diarrhea Manufacturing Base, Sales Area and Its Competitors
Table 80. GSK Drugs for Traveler's Diarrhea Product Portfolios and Specifications
Table 81. GSK Drugs for Traveler's Diarrhea Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 82. GSK Main Business
Table 83. GSK Latest Developments
Table 84. Salix Pharmaceuticals Basic Information, Drugs for Traveler's Diarrhea Manufacturing Base, Sales Area and Its Competitors
Table 85. Salix Pharmaceuticals Drugs for Traveler's Diarrhea Product Portfolios and Specifications
Table 86. Salix Pharmaceuticals Drugs for Traveler's Diarrhea Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 87. Salix Pharmaceuticals Main Business
Table 88. Salix Pharmaceuticals Latest Developments
Table 89. Chiesi Farmaceutici Basic Information, Drugs for Traveler's Diarrhea Manufacturing Base, Sales Area and Its Competitors
Table 90. Chiesi Farmaceutici Drugs for Traveler's Diarrhea Product Portfolios and Specifications
Table 91. Chiesi Farmaceutici Drugs for Traveler's Diarrhea Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 92. Chiesi Farmaceutici Main Business
Table 93. Chiesi Farmaceutici Latest Developments
Table 94. Cosmo Pharmaceuticals Basic Information, Drugs for Traveler's Diarrhea Manufacturing Base, Sales Area and Its Competitors
Table 95. Cosmo Pharmaceuticals Drugs for Traveler's Diarrhea Product Portfolios and Specifications
Table 96. Cosmo Pharmaceuticals Drugs for Traveler's Diarrhea Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 97. Cosmo Pharmaceuticals Main Business
Table 98. Cosmo Pharmaceuticals Latest Developments
Table 99. Nippon Shinyaku Basic Information, Drugs for Traveler's Diarrhea Manufacturing Base, Sales Area and Its Competitors
Table 100. Nippon Shinyaku Drugs for Traveler's Diarrhea Product Portfolios and Specifications
Table 101. Nippon Shinyaku Drugs for Traveler's Diarrhea Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 102. Nippon Shinyaku Main Business
Table 103. Nippon Shinyaku Latest Developments
Table 104. Prokarium Limited Basic Information, Drugs for Traveler's Diarrhea Manufacturing Base, Sales Area and Its Competitors
Table 105. Prokarium Limited Drugs for Traveler's Diarrhea Product Portfolios and Specifications
Table 106. Prokarium Limited Drugs for Traveler's Diarrhea Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 107. Prokarium Limited Main Business
Table 108. Prokarium Limited Latest Developments
Table 109. Scandinavian Biopharma Basic Information, Drugs for Traveler's Diarrhea Manufacturing Base, Sales Area and Its Competitors
Table 110. Scandinavian Biopharma Drugs for Traveler's Diarrhea Product Portfolios and Specifications
Table 111. Scandinavian Biopharma Drugs for Traveler's Diarrhea Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 112. Scandinavian Biopharma Main Business
Table 113. Scandinavian Biopharma Latest Developments
Table 114. Sigmoid Pharma Basic Information, Drugs for Traveler's Diarrhea Manufacturing Base, Sales Area and Its Competitors
Table 115. Sigmoid Pharma Drugs for Traveler's Diarrhea Product Portfolios and Specifications
Table 116. Sigmoid Pharma Drugs for Traveler's Diarrhea Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 117. Sigmoid Pharma Main Business
Table 118. Sigmoid Pharma Latest Developments

LIST OF FIGURES

Figure 1. Picture of Drugs for Traveler's Diarrhea
Figure 2. Drugs for Traveler's Diarrhea Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Drugs for Traveler's Diarrhea Sales Growth Rate 2019-2030 (K Pcs)
Figure 7. Global Drugs for Traveler's Diarrhea Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Drugs for Traveler's Diarrhea Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Anti-motility agents
Figure 10. Product Picture of Bismuth Subsalicylate (Pepto-Bismol)
Figure 11. Product Picture of Antibiotics
Figure 12. Global Drugs for Traveler's Diarrhea Sales Market Share by Type in 2023
Figure 13. Global Drugs for Traveler's Diarrhea Revenue Market Share by Type (2019-2024)
Figure 14. Drugs for Traveler's Diarrhea Consumed in Adult
Figure 15. Global Drugs for Traveler's Diarrhea Market: Adult (2019-2024) & (K Pcs)
Figure 16. Drugs for Traveler's Diarrhea Consumed in Children
Figure 17. Global Drugs for Traveler's Diarrhea Market: Children (2019-2024) & (K Pcs)
Figure 18. Global Drugs for Traveler's Diarrhea Sales Market Share by Application (2023)
Figure 19. Global Drugs for Traveler's Diarrhea Revenue Market Share by Application in 2023
Figure 20. Drugs for Traveler's Diarrhea Sales Market by Company in 2023 (K Pcs)
Figure 21. Global Drugs for Traveler's Diarrhea Sales Market Share by Company in 2023
Figure 22. Drugs for Traveler's Diarrhea Revenue Market by Company in 2023 ($ Million)
Figure 23. Global Drugs for Traveler's Diarrhea Revenue Market Share by Company in 2023
Figure 24. Global Drugs for Traveler's Diarrhea Sales Market Share by Geographic Region (2019-2024)
Figure 25. Global Drugs for Traveler's Diarrhea Revenue Market Share by Geographic Region in 2023
Figure 26. Americas Drugs for Traveler's Diarrhea Sales 2019-2024 (K Pcs)
Figure 27. Americas Drugs for Traveler's Diarrhea Revenue 2019-2024 ($ Millions)
Figure 28. APAC Drugs for Traveler's Diarrhea Sales 2019-2024 (K Pcs)
Figure 29. APAC Drugs for Traveler's Diarrhea Revenue 2019-2024 ($ Millions)
Figure 30. Europe Drugs for Traveler's Diarrhea Sales 2019-2024 (K Pcs)
Figure 31. Europe Drugs for Traveler's Diarrhea Revenue 2019-2024 ($ Millions)
Figure 32. Middle East & Africa Drugs for Traveler's Diarrhea Sales 2019-2024 (K Pcs)
Figure 33. Middle East & Africa Drugs for Traveler's Diarrhea Revenue 2019-2024 ($ Millions)
Figure 34. Americas Drugs for Traveler's Diarrhea Sales Market Share by Country in 2023
Figure 35. Americas Drugs for Traveler's Diarrhea Revenue Market Share by Country in 2023
Figure 36. Americas Drugs for Traveler's Diarrhea Sales Market Share by Type (2019-2024)
Figure 37. Americas Drugs for Traveler's Diarrhea Sales Market Share by Application (2019-2024)
Figure 38. United States Drugs for Traveler's Diarrhea Revenue Growth 2019-2024 ($ Millions)
Figure 39. Canada Drugs for Traveler's Diarrhea Revenue Growth 2019-2024 ($ Millions)
Figure 40. Mexico Drugs for Traveler's Diarrhea Revenue Growth 2019-2024 ($ Millions)
Figure 41. Brazil Drugs for Traveler's Diarrhea Revenue Growth 2019-2024 ($ Millions)
Figure 42. APAC Drugs for Traveler's Diarrhea Sales Market Share by Region in 2023
Figure 43. APAC Drugs for Traveler's Diarrhea Revenue Market Share by Regions in 2023
Figure 44. APAC Drugs for Traveler's Diarrhea Sales Market Share by Type (2019-2024)
Figure 45. APAC Drugs for Traveler's Diarrhea Sales Market Share by Application (2019-2024)
Figure 46. China Drugs for Traveler's Diarrhea Revenue Growth 2019-2024 ($ Millions)
Figure 47. Japan Drugs for Traveler's Diarrhea Revenue Growth 2019-2024 ($ Millions)
Figure 48. South Korea Drugs for Traveler's Diarrhea Revenue Growth 2019-2024 ($ Millions)
Figure 49. Southeast Asia Drugs for Traveler's Diarrhea Revenue Growth 2019-2024 ($ Millions)
Figure 50. India Drugs for Traveler's Diarrhea Revenue Growth 2019-2024 ($ Millions)
Figure 51. Australia Drugs for Traveler's Diarrhea Revenue Growth 2019-2024 ($ Millions)
Figure 52. China Taiwan Drugs for Traveler's Diarrhea Revenue Growth 2019-2024 ($ Millions)
Figure 53. Europe Drugs for Traveler's Diarrhea Sales Market Share by Country in 2023
Figure 54. Europe Drugs for Traveler's Diarrhea Revenue Market Share by Country in 2023
Figure 55. Europe Drugs for Traveler's Diarrhea Sales Market Share by Type (2019-2024)
Figure 56. Europe Drugs for Traveler's Diarrhea Sales Market Share by Application (2019-2024)
Figure 57. Germany Drugs for Traveler's Diarrhea Revenue Growth 2019-2024 ($ Millions)
Figure 58. France Drugs for Traveler's Diarrhea Revenue Growth 2019-2024 ($ Millions)
Figure 59. UK Drugs for Traveler's Diarrhea Revenue Growth 2019-2024 ($ Millions)
Figure 60. Italy Drugs for Traveler's Diarrhea Revenue Growth 2019-2024 ($ Millions)
Figure 61. Russia Drugs for Traveler's Diarrhea Revenue Growth 2019-2024 ($ Millions)
Figure 62. Middle East & Africa Drugs for Traveler's Diarrhea Sales Market Share by Country in 2023
Figure 63. Middle East & Africa Drugs for Traveler's Diarrhea Revenue Market Share by Country in 2023
Figure 64. Middle East & Africa Drugs for Traveler's Diarrhea Sales Market Share by Type (2019-2024)
Figure 65. Middle East & Africa Drugs for Traveler's Diarrhea Sales Market Share by Application (2019-2024)
Figure 66. Egypt Drugs for Traveler's Diarrhea Revenue Growth 2019-2024 ($ Millions)
Figure 67. South Africa Drugs for Traveler's Diarrhea Revenue Growth 2019-2024 ($ Millions)
Figure 68. Israel Drugs for Traveler's Diarrhea Revenue Growth 2019-2024 ($ Millions)
Figure 69. Turkey Drugs for Traveler's Diarrhea Revenue Growth 2019-2024 ($ Millions)
Figure 70. GCC Country Drugs for Traveler's Diarrhea Revenue Growth 2019-2024 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Drugs for Traveler's Diarrhea in 2023
Figure 72. Manufacturing Process Analysis of Drugs for Traveler's Diarrhea
Figure 73. Industry Chain Structure of Drugs for Traveler's Diarrhea
Figure 74. Channels of Distribution
Figure 75. Global Drugs for Traveler's Diarrhea Sales Market Forecast by Region (2025-2030)
Figure 76. Global Drugs for Traveler's Diarrhea Revenue Market Share Forecast by Region (2025-2030)
Figure 77. Global Drugs for Traveler's Diarrhea Sales Market Share Forecast by Type (2025-2030)
Figure 78. Global Drugs for Traveler's Diarrhea Revenue Market Share Forecast by Type (2025-2030)
Figure 79. Global Drugs for Traveler's Diarrhea Sales Market Share Forecast by Application (2025-2030)
Figure 80. Global Drugs for Traveler's Diarrhea Revenue Market Share Forecast by Application (2025-2030)


More Publications